The “House Calls” Trial: A Randomized Controlled Trial to Reduce Racial Disparities in Live Donor Kidney Transplantation: Rationale and Design

Abstract Despite a substantially lower rate of live donor kidney transplantation among Black Americans compared to White Americans, there are few systematic efforts to reduce this racial disparity. This paper describes the rationale and design of a randomized controlled trial evaluating the comparat...

Full description

Saved in:
Bibliographic Details
Published in:Contemporary clinical trials Vol. 33; no. 4; pp. 811 - 818
Main Authors: Rodrigue, James R, Pavlakis, Martha, Egbuna, Ogo, Paek, Matthew, Waterman, Amy D, Mandelbrot, Didier A
Format: Journal Article
Language:English
Published: United States Elsevier Inc 01-07-2012
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Despite a substantially lower rate of live donor kidney transplantation among Black Americans compared to White Americans, there are few systematic efforts to reduce this racial disparity. This paper describes the rationale and design of a randomized controlled trial evaluating the comparative effectiveness of three different educational interventions for increasing live donor kidney transplantation in Black Americans. This trial is a single-site, urn-randomized controlled trial with a planned enrollment of 180 Black Americans awaiting kidney transplantation. Patients are randomized to receive transplant education in one of three education conditions: through group education at their homes (e.g., House Calls), or through group (Group-Based) or individual education (Individual Counseling) in the transplant center. The primary outcome of the trial is the occurrence of a live donor kidney transplant, with secondary outcomes including living donor inquiries and evaluations as well as changes in patient live donor kidney transplantation readiness, willingness, knowledge, and concerns. Sex, age, dialysis status, and quality of life are evaluated as moderating factors. Findings from this clinical trial have the potential to inform strategies for reducing racial disparities in live donor kidney transplantation. Similar trials have been developed recently to broaden the evaluation of House Calls as an innovative disparity-reducing intervention in kidney transplantation.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
Matthew Paek, MA, The Transplant Institute, Beth Israel Deaconess Medical Center, 10 Francis Street, LMOB- 7, Boston, MA 02215, (617) 632-9700, (617) 632-9820 (fax), mpaek@bidmc.harvard.edu
Ogo Egbuna, MD, MSc, Amgen Inc., Mail Stop: 38-2A, Rm. 38 2D-1-2, Thousand Oaks, CA 91320, (805) 447-3153, (805) 375-3398, ogoegbuna@gmail.com
Amy D. Waterman, PhD, General Medical Sciences, Washington University School of Medicine, Campus Box 8005, 660 S. Euclid Ave., St. Louis, MO 62110, (314) 454-8102, (314) 454-5113, awaterma@dom.wustl.edu
Co-Authors
Martha Pavlakis, MD, The Transplant Institute, Beth Israel Deaconess Medical Center, 110 Francis Street, LMOB- 7, Boston, MA 02215, (617) 632-9700, (617) 632-9820 (fax), mpavlaki@bidmc.harvard.edu
Didier A. Mandelbrot, MD, The Transplant Institute, Beth Israel Deaconess Medical Center, 110 Francis Street, LMOB- 7, Boston, MA 02215, (617) 632-9700, (617) 632-9820 (fax), dmandelb@bidmc.harvard.edu
ISSN:1551-7144
1559-2030
DOI:10.1016/j.cct.2012.03.015